Astrazeneca Ab

Fana Hunegnaw

Ingemar Starke

Staffan Po Karlsson

Susanne Alenfalk

Malin Anita Lemurell

Ann-Margret Lindqvist

Mikael Dahlström

Tore Skjaret

Tore Skjäret

Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. 

2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions

Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. 

Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity

2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia

Growing community of inventors

Molndal, Sweden

Fana Hunegnaw